News & AnalysisEdiGene takes in $62mEdiGene Inc, a Chinese biotech firm, has raised about $62 million in financing.ByIris Dorbian21 April 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs